Activation and evasion of antiviral innate immunity by hepatitis C virus.
about
Recognition of human oncogenic viruses by host pattern-recognition receptorsRIG-I in RNA virus recognitionA combined proteomics/genomics approach links hepatitis C virus infection with nonsense-mediated mRNA decayHCV RNA Activates APCs via TLR7/TLR8 While Virus Selectively Stimulates Macrophages Without Inducing Antiviral ResponsesProteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle traffickingLiver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.Innate immune cell networking in hepatitis C virus infectionHepatitis C virus infection: establishment of chronicity and liver disease progressionEmerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infectionElevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C.ISG12a Restricts Hepatitis C Virus Infection through the Ubiquitination-Dependent Degradation Pathway.HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection.Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.Innate detection of hepatitis B and C virus and viral inhibition of the response.Progress in the development of vaccines for hepatitis C virus infection.The role of HCV proteins on treatment outcomes.Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson's Disease.Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers.HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection.Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C.Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy.
P2860
Q27010116-710E91B0-9431-439F-8461-C86CBFE74C6AQ28081618-19D02AA3-0615-4D35-AA4E-3639870698EAQ28115899-7081AD4D-60A5-4B10-B831-9A566C94DC7AQ28276935-A20303AA-1DD5-4363-959E-6EFE015314E7Q28543776-86021EC4-94BF-4905-95D5-06CB848AEFDCQ30300575-CCC783F4-84C2-48FB-8D1F-B63C9B69AF88Q34341382-A2D54D57-05C2-4353-BFA5-D0E3A6336AA7Q35728873-F17DD07F-6563-47E9-B1E8-650EB36BE8ECQ36460968-F06E5427-0AED-4C5C-8304-0F4E25217682Q36675098-790258A0-09EB-43FD-9642-C04E1552A513Q37093500-0B825D7A-1EDD-4A21-99C5-EE34EEE4DC85Q37437190-4CB3C803-E05A-4F58-96E8-9471E0046BBAQ37654431-D8982BC0-1769-4356-BFE3-088657787271Q38223279-C635EBC0-EADA-48C4-BAD1-E4A6A3CE3DC6Q38248452-4754A282-6389-4B18-B28B-4F8CD5A57C82Q38270733-3D114DD3-8B81-4D5C-9941-62ACA418FFFCQ38560972-A4B0BE26-6E8E-4133-950D-8154B4F8C2D0Q38635596-D16AFFF1-77BA-494C-A942-3490EB97D7AFQ38668968-7386A3AF-1B9A-4E77-A124-2245A509FBFBQ38974698-9FD0F4D4-FD34-44F0-A575-84D5144280E3Q39771933-01F61F13-CC1A-4F78-A4E8-C696D77D9787Q40105724-7EF32678-5AA1-4334-9868-ADCA501583A5Q40577279-C652F615-BC7C-4AC6-8F13-EAC958C4D14FQ40688859-D95B676B-5C82-4C7C-A267-BDA72A7C8AB1Q41016420-073BC4CE-208E-41FC-97E2-80BDA17EB8FCQ42685448-6F33DEAC-20F0-45C8-8762-8DD5A8DFCD24
P2860
Activation and evasion of antiviral innate immunity by hepatitis C virus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Activation and evasion of antiviral innate immunity by hepatitis C virus.
@ast
Activation and evasion of antiviral innate immunity by hepatitis C virus.
@en
type
label
Activation and evasion of antiviral innate immunity by hepatitis C virus.
@ast
Activation and evasion of antiviral innate immunity by hepatitis C virus.
@en
prefLabel
Activation and evasion of antiviral innate immunity by hepatitis C virus.
@ast
Activation and evasion of antiviral innate immunity by hepatitis C virus.
@en
P2860
P1476
Activation and evasion of antiviral innate immunity by hepatitis C virus
@en
P2093
Stacy M Horner
P2860
P304
P356
10.1016/J.JMB.2013.10.032
P407
P577
2013-10-31T00:00:00Z